Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

8.01
-0.2100-2.55%
Volume:487.26K
Turnover:3.94M
Market Cap:1.10B
PE:-2.09
High:8.31
Open:8.06
Low:7.99
Close:8.22
Loading ...

Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Business Wire
·
25 Nov 2024

TD Cowen Keeps Their Buy Rating on Vir Biotechnology (VIR)

TIPRANKS
·
20 Nov 2024

Vir Biotechnology Price Target Maintained With a $19.00/Share by Needham

Dow Jones
·
20 Nov 2024

U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart

Reuters
·
20 Nov 2024

Vir Biotechnology announces results from SOLSTICE trial

TIPRANKS
·
19 Nov 2024

BRIEF-Vir Biotechnology Says Tobevibart And Elebsiran Achieve 100% Virologic Suppression At Week 24

Reuters
·
19 Nov 2024

Vir Biotechnology Inc - Ema Issues Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran

THOMSON REUTERS
·
19 Nov 2024

Vir Biotechnology Inc - Phase 3 Eclipse Program to Begin in First Half of 2025

THOMSON REUTERS
·
19 Nov 2024

Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program

THOMSON REUTERS
·
19 Nov 2024

Vir Biotechnology Inc - Tobevibart and Elebsiran Achieve 100% Virologic Suppression at Week 24

THOMSON REUTERS
·
19 Nov 2024

Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program

Business Wire
·
19 Nov 2024

Vir Biotechnology Prospective Treatment for Hepatitis Delta Gets EU Advisory Committee Recommendation

MT Newswires Live
·
19 Nov 2024

Vir Biotechnology gets positive opinion on orphan drug designation for Tobevibar

TIPRANKS
·
19 Nov 2024

Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta From European Medicines Agency

THOMSON REUTERS
·
19 Nov 2024

Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency

Business Wire
·
19 Nov 2024

What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday?

Benzinga
·
16 Nov 2024